Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Lilly nociceptin receptor antagonist proves useful for various conditions

May 2, 2014

Roche and NCI present preclinical data for RG-7787

May 2, 2014

RP-5063 shows robust efficacy and safety in phase II REFRESH trial

May 2, 2014

NKTT-320 activates immunostimulatory functions of human iNKTs

May 2, 2014

Preclinical results presented for InvaplexAR, a Shigella vaccine

April 30, 2014

IMM-H007 reduces atherosclerotic plaque in mice and increases circulating HDL levels

April 30, 2014

Novel agent for neuropsychiatric disorders presented by IntraCellular Therapies

April 30, 2014

CCTA-1523 reverses ABCG2-mediated multidrug resistance in cancer cells

April 30, 2014

Jubilant Biosys identifies compounds active against mutant EGFR

April 30, 2014

Chloroquine derivative developed for improving anticancer activity

April 30, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...